Nicotinamide Riboside Protects Retinal Ganglion Cells in Mice
Author Information
Author(s): Zhang Nan, Li Ying, Zhang Xian, Chrenek Micah A., Wang Jiaxing, Girardot Preston E., Sellers Jana T., Brenner Charles, Cui Xiangqin, Geisert Eldon E., Nickerson John, Boatright Jeffrey H.
Primary Institution: Emory University
Hypothesis
Does oral administration of nicotinamide riboside protect retinal ganglion cells from neurodegeneration in DBA/2J mice?
Conclusion
Nicotinamide riboside treatment significantly preserved retinal ganglion cell and axon numbers, potentially preserving retinal function in aged DBA/2J mice.
Supporting Evidence
- NR treatment significantly increased retinal NAD+ levels in aged DBA/2J mice.
- NR treatment preserved visual function in aged DBA/2J mice.
- NR treatment significantly protected against total RGC loss and optic nerve atrophy.
- NR treatment delayed IOP elevation in aged DBA/2J mice.
- NR treatment prevented iris depigmentation in aged DBA/2J mice.
Takeaway
Giving a special vitamin called nicotinamide riboside to mice helps protect their eyes from getting worse as they get older.
Methodology
Mice were given oral nicotinamide riboside or nicotinamide at different doses, and their retinal health was assessed through various tests including intraocular pressure measurement and retinal cell counting.
Potential Biases
Potential bias in treatment allocation and assessment due to lack of blinding in some procedures.
Limitations
The study primarily used a mouse model, which may not fully replicate human glaucoma conditions.
Participant Demographics
Adult DBA/2J mice, both male and female.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website